Apollo Hospitals shares hit record high after Macquarie double upgrade, projects 20% upside

Apollo Hospitals shares have surged to a record high following a significant upgrade from Macquarie. The global investment bank raised its rating on the stock, citing that the current market valuation has become attractive after a period of correction. The firm believes the negative sentiment regarding the company's earnings is no longer justified.
This development matters to investors as it signals a shift in market perception regarding Apollo's growth trajectory. Macquarie notes that the challenges associated with the company's recent expansion of hospital beds are now priced into the stock. The firm projects that new capacity is ramping up efficiently, which should support future earnings growth.
Investors should monitor the pace of new hospital openings and the subsequent improvement in operational margins. Keeping an eye on the quarterly earnings reports will be crucial to see if the operational improvements match the optimism shown by the brokerage.
Excerpt from CNBC-TV18
Published On Nov 20, 2026 | 12:07 IST Last Updated On Nov 20, 2026 | 12:07 IST Apollo Hospitals rallied to a record high following a major rating upgrade, driven by robust quarterly earnings, improved bed occupancy, and surging inpatient volumes. Meanwhile, fellow healthcare peer Max Healthcare also secured a bullish…Read the original at CNBC-TV18
Affected stocks
Bullish1 stockBull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Apollo Hospitals Enterprise (APOLLOHOSP).
- Category: Results.
- AI reads the tone as positive (potentially bullish) for the stock.
- Assessed as a significant, market-relevant update.
Why it matters
A meaningful update for Apollo Hospitals Enterprise worth tracking. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.









